[期刊]
  • 《Pathology Research and Practice》 2022年237卷

摘要 : Hepatocellular carcinoma (HCC) is characterized by a low mutation burden and a relatively low number of tumor-infiltrating lymphocytes (TILs), making still difficult to identify targets for specific therapies. The aim of this stud... 展开

相关作者
相关关键词